PIM1 protein expression was slightly, but not significantly, higher in SCLC, as 45.8% of them (11 sections) showed quite intense immunostaining (IRS 2 in 9 (37.5%) and IRS 3 in 2 (8.3%) samples). This evidence concerns the gene PIM1 and small cell lung carcinoma.